萊寶高科(002106.SZ):目前沒有考慮發展ChatGPT技術
格隆匯5月5日丨有投資者在投資者互動平台向萊寶高科(002106.SZ)提問,“公司除了做觸摸屏,有沒有考慮發展ChatGPT技術,人工智能和芯片方面的業務?或者進行一些併購?”
萊寶高科回覆稱,ChatGPT技術與公司自身的資源和條件存在較大差異,公司目前沒有考慮發展ChatGPT技術;公司結合自身資源條件,積極關注人工智能和芯片方面的行業發展,後續如有合適機會,公司將適時擇機尋找適合公司自身資源和條件的相關發展機會,具體進展存在較大的不確定性,請您以公司正式公吿信息為準,謹慎理性投資。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.